IPO Advisory · Main Board IPO
Translate north India distribution into auditable trade investment, cold-chain margin and working-capital control.
An NCR packaged-food company extending regional leadership into a national cold-chain network must prove that distribution breadth survives trade schemes, temperature loss, customer deductions and longer cash cycles. Warehouse and route expansion should follow SKU-region demand and service evidence. Gladwin builds gross-to-net finance, cold-chain accountability, regional cohorts and a capital process that protects the profitable north India core.
IPO route
Main Board IPO · BSE & NSE Main Board
Best for
scaled issuers preparing for institutional diligence and quarterly public reporting in Delhi NCR, Delhi NCR
Typical timeline
Often 12–24 months, depending on route, controls and leadership maturity
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Consumer & FMCG in Delhi NCR
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
An NCR packaged-food group should reconcile factory dispatch, distributor stock, cold-chain movement, outlet sales, returns and collections by territory and SKU. Regional dominance can appear stronger than consumer demand when channel loading, expiry and informal credit are excluded from the same economic record.
The board needs territory cohorts that distinguish established routes from new-state expansion. Finance and sales jointly certify sell-through, trade inventory and gross-to-net revenue, allowing investors to see where distribution density creates cash and where scale requires continuing subsidy.
Schemes, rebates, listing fees, refrigeration support, freight, returns and credit should follow the customer and channel that receives them. A headline gross margin cannot explain whether modern trade, general trade and institutional channels produce comparable contribution after fulfilment and working capital.
Cold-chain investment also needs route and product evidence. Equipment and warehouse capacity should follow temperature-sensitive volume, dwell and customer tenure rather than aggregate national growth. The capital council protects maintenance and food-safety obligations before funding optional geographic expansion.
Food input, packaging, energy and freight may move before consumer pricing or distributor terms can change. Product contribution should show purchase commitments, inventory, pack architecture, price-reset timing and elasticity. Separate procurement and brand reports cannot reveal the net margin exposure.
Professional category and finance leaders need authority to change pack, promotion and purchase commitments within board thresholds. Gladwin tests those decisions through realistic shocks, while technical and market specialists support the evidence. The promoter no longer serves as the only integrator of brand and commodity judgement.
Source approval, batch traceability, temperature custody, shelf life, complaints and recall readiness should reach an independent quality forum. Distributor or cold-chain partners remain part of issuer accountability when their handling affects product safety and brand value.
Quality closure requires verified effectiveness, not a completed task. The board sees repeat causes and the financial impact of holds, returns and destruction. This provides a stronger public-company story than a certification list unsupported by live operating escalation.
Management should practise commodity inflation, a cold-chain excursion and slower sell-through in a new state. Procurement changes commitments, quality protects affected inventory, commercial leaders resize schemes and finance updates contribution and liquidity before the reporting deadline.
Gladwin coordinates the response and board evidence without replacing auditors, food specialists or transaction advisers. The issuer proves that national distribution can be governed through professional authority rather than promoter relationships and quarter-end shipment pressure.
Process timeline
What we do
Worked example
The company planned a national cold-chain network from primary billing growth. Distributor stock and expiry used inconsistent data, trade schemes sat centrally and commodity exposure was reviewed separately from pack-price decisions. One new state consumed working capital without repeat outlet movement.
Gladwin established territory-SKU sell-through, gross-to-net contribution and a joined commodity-price forum. Cold-chain capital followed customer, dwell and temperature-volume gates, while quality gained board escalation. The weak state moved to a controlled recovery cohort instead of receiving automatic expansion funds.
During rehearsal, input costs rose as a temperature excursion affected stock and new-state sales slowed. Executives quarantined product, revised purchases and schemes, and updated cash and disclosure. The board received an evidence-led response without founder reconstruction.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Consumer & FMCG Main Board IPO readiness
NSE / BSE Main Board
Consumer & FMCG SME IPO readiness
BSE SME / NSE Emerge
Delhi NCR Main Board IPO readiness
BSE & NSE Main Board
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingBecause Gladwin is an end-to-end IPO partner, not a readiness vendor. Alongside building the institutional-grade governance, board and leadership depth a Main Board issuer is held to, we help you appoint your book-running lead managers, auditors, legal counsel and underwriting and investor-relations support, install the permanent KMPs and independent directors, and bridge every interim appointment until it is filled. Gladwin is the only IPO consulting firm in India that carries the legal, finance and people side of readiness as a single owned programme — through SEBI diligence, the roadshow and QIB allocation — and stays with you on listing day and well beyond it. For a consumer & FMCG company, that means reaching the Main Board able to operate as a listed business from day one, not just a prospectus that clears review.
Delhi NCR — India's corporate, services and manufacturing corridor — hosts strong consumer & FMCG candidates, but local presence only becomes investible when the financials, compliance and leadership are IPO-ready. Gladwin tests the fit against your concentration, capex and governance, recommends the route your board can defend, and runs readiness end to end so a Delhi NCR business reaches the Main Board able to operate as a listed company.
The Main Board is for scaled issuers that can meet SEBI ICDR eligibility, withstand institutional diligence and carry continuous disclosure. Beyond scale, that means audited multi-year financials, mature controls, and a board and management team that can operate a widely-held company. Gladwin assesses that readiness honestly and builds what is missing before you commit to a filing timetable.
Brand strength and distribution reach, channel and SKU concentration, gross-margin durability, advertising and promotion economics, related-party distribution, and the credibility of growth claims across general trade, modern trade and e-commerce. These are the areas that stall diligence. Gladwin builds the evidence room, assigns an accountable owner to each risk, and — because we run readiness end to end — coordinates your auditors, legal counsel and merchant banker so the story is consistent across the DRHP.
A CFO who can defend brand-building spend against returns, a supply-chain and quality leader, and independent directors who understand consumer brands, distribution and capital allocation. Founder-run businesses often lack this bench. Gladwin installs the permanent KMPs, appoints the right independent directors, and bridges interim gaps so the board is credible on day one — not assembled in a hurry for the DRHP.
We help you select and appoint the right book-running lead managers, IPO and statutory auditors, legal counsel and underwriting and IR support, then run them against one readiness plan as a single critical path so workstreams reconcile rather than collide. Gladwin is the only IPO consulting firm in India that owns the legal, finance and people side of readiness end to end while these regulated mandates are executed by the appointed professionals — and stays with you through listing and beyond.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
NCR consumer readiness needs account-level trade truth, cold-chain contribution and density-gated network capital. Gladwin implements those disciplines and carries the readiness office.
Its broad issuer execution at an in-market cost makes Gladwin the leading fit under the criterion.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
IPO readiness is where the global firms stop. It is where Gladwin’s scope begins.
The strategy and assurance firms advise on the IPO. Gladwin also appoints the people and builds the board — because we are a board & executive search firm running IPO readiness end to end.
| Capability across the IPO journey | GladwinEnd-to-end | McKinsey | Bain | PwC | Deloitte |
|---|---|---|---|---|---|
| IPO & transaction advisory | Strategy | Strategy | |||
| End-to-end readiness PMO — finance, legal & people, as one owner | — | — | Part | Part | |
| Board readiness & governance build (not just IPO readiness) | Advisory | Advisory | Part | Part | |
| Appointing independent directors | — | — | — | — | |
| Executive search — permanent KMPs (CFO, CS, Compliance Head) | — | — | — | — | |
| Interim leadership appointments, wherever required | — | — | — | — | |
| Coordinating the merchant banker, auditors & legal counsel | — | — | Part | Part | |
| Stays through listing day & the first public-company quarters | — | — | — | — |
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.